4 0 1 0 1 B-upper_bound
priapism 2 10 2 10 B-chronic_disease
episodes 11 19 11 19 O
that 20 24 20 24 O
require 25 32 25 32 O
a 33 34 33 34 O
visit 35 40 35 40 O
to 41 43 41 43 O
a 44 45 44 45 O
medical 46 53 46 53 O
facility 54 62 54 62 O
( 63 64 63 64 O
without 64 71 64 71 O
inpatient 72 81 72 81 O
admission 82 91 82 91 O
) 91 92 91 92 O
are 93 96 93 96 O
sufficient 97 107 97 107 O
to 108 110 108 110 O
meet 111 115 111 115 O
criterion 116 125 116 125 O

Advanced 0 8 126 134 O
liver 9 14 135 140 B-chronic_disease
disease 15 22 141 148 I-chronic_disease

Any 0 3 149 152 O
contraindications 4 21 153 170 O
to 22 24 171 173 O
the 25 28 174 177 O
use 29 32 178 181 O
of 33 35 182 184 O
plerixafor 36 46 185 195 B-allergy_name
during 47 53 196 202 O
the 54 57 203 206 O
mobilization 58 70 207 219 O
of 71 73 220 222 O
hematopoietic 74 87 223 236 O
stem 88 92 237 241 O
cells 93 98 242 247 O

Any 0 3 248 251 O
history 4 11 252 259 O
of 12 14 260 262 O
severe 15 21 263 269 B-chronic_disease
cerebral 22 30 270 278 I-chronic_disease
vasculopathy 31 43 279 291 I-chronic_disease

Any 0 3 292 295 O
prior 4 9 296 301 O
or 10 12 302 304 O
current 13 20 305 312 O
malignancy 21 31 313 323 B-cancer
or 32 34 324 326 O
immunodeficiency 35 51 327 343 B-chronic_disease
disorder 52 60 344 352 I-chronic_disease

Baseline 0 8 353 361 B-clinical_variable
prothrombin 9 20 362 373 I-clinical_variable
time 21 25 374 378 I-clinical_variable
or 26 28 379 381 O
partial 29 36 382 389 B-clinical_variable
thromboplastin 37 51 390 404 I-clinical_variable
time 52 56 405 409 I-clinical_variable
> 57 58 410 411 O
1.5× 58 62 411 415 B-lower_bound
ULN 63 66 416 419 I-lower_bound

Be 0 2 420 422 O
≥12 3 6 423 426 O
and 7 10 427 430 O
≤50 11 14 431 434 O
of 15 17 435 437 O
age 18 21 438 441 B-age
at 22 24 442 444 O
time 25 29 445 449 O
of 30 32 450 452 O
consent 33 40 453 460 O

Clinically 0 10 461 471 O
significant 11 22 472 483 O
and 23 26 484 487 O
active 27 33 488 494 O
bacterial 34 43 495 504 B-chronic_disease
, 43 44 504 505 O
viral 45 50 506 511 B-chronic_disease
, 50 51 511 512 O
fungal 52 58 513 519 B-chronic_disease
, 58 59 519 520 O
or 60 62 521 523 O
parasitic 63 72 524 533 B-chronic_disease
infection 73 82 534 543 I-chronic_disease

Diagnosis 0 9 544 553 O
of 10 12 554 556 O
sickle 13 19 557 563 B-chronic_disease
cell 20 24 564 568 I-chronic_disease
disease 25 32 569 576 I-chronic_disease
( 33 34 577 578 I-chronic_disease
SCD 34 37 578 581 I-chronic_disease
) 37 38 581 582 I-chronic_disease
, 38 39 582 583 O
with 40 44 584 588 O
either 45 51 589 595 O
βS 52 54 596 598 O
/ 54 55 598 599 O
βS 55 57 599 601 O
or 58 60 602 604 O
βS 61 63 605 607 O
/ 63 64 607 608 O
β0 64 66 608 610 O
or 67 69 611 613 O
βS 70 72 614 616 O
/ 72 73 616 617 O
β+ 73 75 617 619 O
genotype 76 84 620 628 O

Diagnosis 0 9 629 638 O
of 10 12 639 641 O
significant 13 24 642 653 O
psychiatric 25 36 654 665 B-chronic_disease
disorder 37 45 666 674 I-chronic_disease
of 46 48 675 677 O
the 49 52 678 681 O
subject 53 60 682 689 O
that 61 65 690 694 O
, 65 66 694 695 O
in 67 69 696 698 O
the 70 73 699 702 O
Investigator 74 86 703 715 O
's 86 88 715 717 O
judgment 89 97 718 726 O
, 97 98 726 727 O
could 99 104 728 733 O
seriously 105 114 734 743 O
impede 115 121 744 750 O
the 122 125 751 754 O
ability 126 133 755 762 O
to 134 136 763 765 O
participate 137 148 766 777 O
in 149 151 778 780 O
the 152 155 781 784 O
study 156 161 785 790 O

For 0 3 791 794 O
the 4 7 795 798 O
purposes 8 16 799 807 O
of 17 19 808 810 O
this 20 24 811 815 O
study 25 30 816 821 O
, 30 31 821 822 O
a 32 33 823 824 O
severe 34 40 825 831 O
VOE 41 44 832 835 B-chronic_disease
is 45 47 836 838 O
defined 48 55 839 846 O
as 56 58 847 849 O
an 59 61 850 852 O
event 62 67 853 858 O
with 68 72 859 863 O
no 73 75 864 866 O
medically 76 85 867 876 O
determined 86 96 877 887 O
cause 97 102 888 893 O
other 103 108 894 899 O
than 109 113 900 904 O
a 114 115 905 906 O
vaso 116 120 907 911 O
- 120 121 911 912 O
occlusion 121 130 912 921 O
, 130 131 921 922 O
requiring 132 141 923 932 O
a 142 143 933 934 O
≥ 144 145 935 936 O
24 146 148 937 939 B-lower_bound
- 148 149 939 940 I-lower_bound
hour 149 153 940 944 I-lower_bound
hospital 154 162 945 953 O
or 163 165 954 956 O
Emergency 166 175 957 966 O
Room 176 180 967 971 O
( 181 182 972 973 O
ER 182 184 973 975 O
) 184 185 975 976 O
observation 186 197 977 988 O
unit 198 202 989 993 O
visit 203 208 994 999 O
or 209 211 1000 1002 O
at 212 214 1003 1005 O
least 215 220 1006 1011 O
2 221 222 1012 1013 O
visits 223 229 1014 1020 O
to 230 232 1021 1023 O
a 233 234 1024 1025 O
day 235 238 1026 1029 O
unit 239 243 1030 1034 O
or 244 246 1035 1037 O
ER 247 249 1038 1040 O
over 250 254 1041 1045 O
72 255 257 1046 1048 B-lower_bound
hours 258 263 1049 1054 I-lower_bound
with 264 268 1055 1059 O
both 269 273 1060 1064 O
visits 274 280 1065 1071 O
requiring 281 290 1072 1081 O
intravenous 291 302 1082 1093 B-treatment
treatment 303 312 1094 1103 I-treatment

Have 0 4 1104 1108 O
been 5 9 1109 1113 O
treated 10 17 1114 1121 O
and 18 21 1122 1125 O
followed 22 30 1126 1134 O
for 31 34 1135 1138 O
at 35 37 1139 1141 O
least 38 43 1142 1147 O
the 44 47 1148 1151 O
past 48 52 1152 1156 B-upper_bound
24 53 55 1157 1159 I-upper_bound
months 56 62 1160 1166 I-upper_bound
prior 63 68 1167 1172 I-upper_bound
to 69 71 1173 1175 O
Informed 72 80 1176 1184 O
Consent 81 88 1185 1192 O
in 89 91 1193 1195 O
medical 92 99 1196 1203 O
center(s 100 108 1204 1212 O
) 108 109 1212 1213 O
that 110 114 1214 1218 O
maintained 115 125 1219 1229 O
detailed 126 134 1230 1238 O
records 135 142 1239 1246 O
on 143 145 1247 1249 O
SCD 146 149 1250 1253 B-treatment
history 150 157 1254 1261 O

Have 0 4 1262 1266 O
either 5 11 1267 1273 O
experienced 12 23 1274 1285 O
hydroxyurea 24 35 1286 1297 B-treatment
( 36 37 1298 1299 I-treatment
HU 37 39 1299 1301 I-treatment
) 39 40 1301 1302 I-treatment
failure 41 48 1303 1310 O
at 49 51 1311 1313 O
any 52 55 1314 1317 O
point 56 61 1318 1323 O
in 62 64 1324 1326 O
the 65 68 1327 1330 O
past 69 73 1331 1335 O
or 74 76 1336 1338 O
must 77 81 1339 1343 O
have 82 86 1344 1348 O
intolerance 87 98 1349 1360 O
to 99 101 1361 1363 O
HU 102 104 1364 1366 O
( 105 106 1367 1368 O
defined 106 113 1368 1375 O
as 114 116 1376 1378 O
patient 117 124 1379 1386 O
being 125 130 1387 1392 O
unable 131 137 1393 1399 O
to 138 140 1400 1402 O
continue 141 149 1403 1411 O
to 150 152 1412 1414 O
take 153 157 1415 1419 O
HU 158 160 1420 1422 O
per 161 164 1423 1426 O
PI 165 167 1427 1429 O
judgement 168 177 1430 1439 O
) 177 178 1439 1440 O

Have 0 4 1441 1445 O
severe 5 11 1446 1452 O
SCD 12 15 1453 1456 B-chronic_disease

Immediate 0 9 1457 1466 O
family 10 16 1467 1473 O
member 17 23 1474 1480 O
with 24 28 1481 1485 O
a 29 30 1486 1487 O
known 31 36 1488 1493 O
or 37 39 1494 1496 O
suspected 40 49 1497 1506 O
Familial 50 58 1507 1515 B-chronic_disease
Cancer 59 65 1516 1522 I-chronic_disease
Syndrome 66 74 1523 1531 I-chronic_disease

In 0 2 1532 1534 O
subjects 3 11 1535 1543 O
< 12 13 1544 1545 O
18 13 15 1545 1547 B-upper_bound
years 16 21 1548 1553 I-upper_bound
of 22 24 1554 1556 O
age 25 28 1557 1560 B-age
, 28 29 1560 1561 O
these 30 35 1562 1567 O
MRI 36 39 1568 1571 B-treatment
findings 40 48 1572 1580 O
are 49 52 1581 1584 O
exclusionary 53 65 1585 1597 O
, 65 66 1597 1598 O
unless 67 73 1599 1605 O
in 74 76 1606 1608 O
the 77 80 1609 1612 O
opinion 81 88 1613 1620 O
of 89 91 1621 1623 O
the 92 95 1624 1627 O
Investigator 96 108 1628 1640 O
, 108 109 1640 1641 O
a 110 111 1642 1643 O
liver 112 117 1644 1649 B-treatment
biopsy 118 124 1650 1656 I-treatment
could 125 130 1657 1662 O
provide 131 138 1663 1670 O
additional 139 149 1671 1681 O
data 150 154 1682 1686 O
to 155 157 1687 1689 O
confirm 158 165 1690 1697 O
eligibility 166 177 1698 1709 O
and 178 181 1710 1713 O
would 182 187 1714 1719 O
be 188 190 1720 1722 O
safe 191 195 1723 1727 O
to 196 198 1728 1730 O
perform 199 206 1731 1738 O

Inadequate 0 10 1739 1749 O
bone 11 15 1750 1754 O
marrow 16 22 1755 1761 O
function 23 31 1762 1770 O
, 31 32 1770 1771 O
as 33 35 1772 1774 O
defined 36 43 1775 1782 O
by 44 46 1783 1785 O
an 47 49 1786 1788 O
absolute 50 58 1789 1797 B-clinical_variable
neutrophil 59 69 1798 1808 I-clinical_variable
count 70 75 1809 1814 I-clinical_variable
of 76 78 1815 1817 O
< 79 80 1818 1819 O
1000/µL 81 88 1820 1827 B-upper_bound
( 89 90 1828 1829 O
< 90 91 1829 1830 O
500/µL 92 98 1831 1837 B-upper_bound
for 99 102 1838 1841 O
subjects 103 111 1842 1850 O
on 112 114 1851 1853 O
HU 115 117 1854 1856 B-treatment
treatment 118 127 1857 1866 I-treatment
) 127 128 1866 1867 O
or 129 131 1868 1870 O
a 132 133 1871 1872 O
platelet 134 142 1873 1881 B-clinical_variable
count 143 148 1882 1887 I-clinical_variable
< 149 150 1888 1889 O
120,000/µL 151 161 1890 1900 B-upper_bound
( 162 163 1901 1902 O
without 163 170 1902 1909 O
hypersplenism 171 184 1910 1923 B-chronic_disease
) 184 185 1923 1924 O

Karnofsky 0 9 1925 1934 B-clinical_variable
performance 10 21 1935 1946 I-clinical_variable
status 22 28 1947 1953 I-clinical_variable
of 29 31 1954 1956 O
≥ 32 33 1957 1958 O
60 34 36 1959 1961 B-lower_bound
( 37 38 1962 1963 O
≥16 38 41 1963 1966 O
years 42 47 1967 1972 I-lower_bound
of 48 50 1973 1975 O
age 51 54 1976 1979 B-age
) 54 55 1979 1980 O

MRI 0 3 1981 1984 B-treatment
findings 4 12 1985 1993 O
suggestive 13 23 1994 2004 O
of 24 26 2005 2007 O
active 27 33 2008 2014 O
hepatitis 34 43 2015 2024 B-chronic_disease
, 43 44 2024 2025 O
significant 45 56 2026 2037 O
fibrosis 57 65 2038 2046 B-chronic_disease
, 65 66 2046 2047 O
inconclusive 67 79 2048 2060 O
evidence 80 88 2061 2069 O
of 89 91 2070 2072 O
cirrhosis 92 101 2073 2082 B-chronic_disease
, 101 102 2082 2083 O
or 103 105 2084 2086 O
liver 106 111 2087 2092 B-clinical_variable
iron 112 116 2093 2097 I-clinical_variable
concentration 117 130 2098 2111 I-clinical_variable
≥15 131 134 2112 2115 O
mg 135 137 2116 2118 I-lower_bound
/ 137 138 2118 2119 I-lower_bound
g 138 139 2119 2120 I-lower_bound
require 140 147 2121 2128 O
follow 148 154 2129 2135 O
- 154 155 2135 2136 O
up 155 157 2136 2138 O
liver 158 163 2139 2144 B-treatment
biopsy 164 170 2145 2151 I-treatment
in 171 173 2152 2154 O
subjects 174 182 2155 2163 O
≥18 183 186 2164 2167 O
years 187 192 2168 2173 I-lower_bound
of 193 195 2174 2176 O
age 196 199 2177 2180 B-age

Magnetic 0 8 2181 2189 B-treatment
Resonance 9 18 2190 2199 I-treatment
Imaging 19 26 2200 2207 I-treatment
( 27 28 2208 2209 I-treatment
MRI 28 31 2209 2212 I-treatment
) 31 32 2212 2213 I-treatment
of 33 35 2214 2216 O
the 36 39 2217 2220 O
liver 40 45 2221 2226 O
demonstrating 46 59 2227 2240 O
clear 60 65 2241 2246 O
evidence 66 74 2247 2255 O
of 75 77 2256 2258 O
cirrhosis 78 87 2259 2268 B-chronic_disease

Participation 0 13 2269 2282 O
in 14 16 2283 2285 O
another 17 24 2286 2293 B-treatment
clinical 25 33 2294 2302 I-treatment
study 34 39 2303 2308 I-treatment
with 40 44 2309 2313 I-treatment
an 45 47 2314 2316 I-treatment
investigational 48 63 2317 2332 I-treatment
drug 64 68 2333 2337 I-treatment
within 69 75 2338 2344 O
30 76 78 2345 2347 B-upper_bound
days 79 83 2348 2352 I-upper_bound
of 84 86 2353 2355 O
Screening 87 96 2356 2365 O

Patients 0 8 2366 2374 O
needing 9 16 2375 2382 O
curative 17 25 2383 2391 B-treatment
anticoagulation 26 41 2392 2407 I-treatment
therapy 42 49 2408 2415 I-treatment
during 50 56 2416 2422 O
the 57 60 2423 2426 O
period 61 67 2427 2433 O
of 68 70 2434 2436 O
conditioning 71 83 2437 2449 O
through 84 91 2450 2457 O
platelet 92 100 2458 2466 B-treatment
engraftment 101 112 2467 2478 I-treatment

Persistent 0 10 2479 2489 O
aspartate 11 20 2490 2499 B-clinical_variable
transaminase 21 33 2500 2512 I-clinical_variable

Positive 0 8 2513 2521 O
for 9 12 2522 2525 O
presence 13 21 2526 2534 O
of 22 24 2535 2537 O
human 25 30 2538 2543 B-chronic_disease
immunodeficiency 31 47 2544 2560 I-chronic_disease
virus 48 53 2561 2566 I-chronic_disease
type 54 58 2567 2571 I-chronic_disease
1 59 60 2572 2573 I-chronic_disease
or 61 63 2574 2576 I-chronic_disease
2 64 65 2577 2578 I-chronic_disease
( 66 67 2579 2580 O
HIV-1 67 72 2580 2585 B-chronic_disease
and 73 76 2586 2589 O
HIV-2 77 82 2590 2595 B-chronic_disease
) 82 83 2595 2596 O
, 83 84 2596 2597 O
hepatitis 85 94 2598 2607 B-chronic_disease
B 95 96 2608 2609 I-chronic_disease
virus 97 102 2610 2615 I-chronic_disease
( 103 104 2616 2617 I-chronic_disease
HBV 104 107 2617 2620 I-chronic_disease
) 107 108 2620 2621 I-chronic_disease
, 108 109 2621 2622 O
or 110 112 2623 2625 O
hepatitis 113 122 2626 2635 B-chronic_disease
C 123 124 2636 2637 I-chronic_disease
( 125 126 2638 2639 I-chronic_disease
HCV 126 129 2639 2642 I-chronic_disease
) 129 130 2642 2643 I-chronic_disease

Pregnancy 0 9 2644 2653 B-pregnancy

Prior 0 5 2654 2659 O
receipt 6 13 2660 2667 O
of 14 16 2668 2670 O
an 17 19 2671 2673 O
allogeneic 20 30 2674 2684 B-treatment
transplant 31 41 2685 2695 I-treatment

Prior 0 5 2696 2701 O
receipt 6 13 2702 2709 O
of 14 16 2710 2712 O
gene 17 21 2713 2717 B-treatment
therapy 22 29 2718 2725 I-treatment

Unable 0 6 2726 2732 O
to 7 9 2733 2735 O
receive 10 17 2736 2743 O
RBC 18 21 2744 2747 B-treatment
transfusion 22 33 2748 2759 I-treatment

a 0 1 2760 2761 O
Lansky 2 8 2762 2768 B-clinical_variable
performance 9 20 2769 2780 I-clinical_variable
status 21 27 2781 2787 I-clinical_variable
of 28 30 2788 2790 O
≥60 31 34 2791 2794 O
( 35 36 2795 2796 O
< 36 37 2796 2797 O
16 37 39 2797 2799 B-upper_bound
years 40 45 2800 2805 I-upper_bound
of 46 48 2806 2808 O
age 49 52 2809 2812 B-age
) 52 53 2812 2813 O

abnormal 0 8 2814 2822 B-clinical_variable
transcranial 9 21 2823 2835 I-clinical_variable
Doppler 22 29 2836 2843 I-clinical_variable
[ 30 31 2844 2845 O
≥200 31 35 2845 2849 O
cm 36 38 2850 2852 I-lower_bound
/ 38 39 2852 2853 I-lower_bound
sec 39 42 2853 2856 I-lower_bound
] 42 43 2856 2857 O
needing 44 51 2858 2865 O
chronic 52 59 2866 2873 B-treatment
transfusion 60 71 2874 2885 I-treatment

absence 0 7 2886 2893 O
of 8 10 2894 2896 O
adequate 11 19 2897 2905 B-contraception_consent
contraception 20 33 2906 2919 I-contraception_consent
for 34 37 2920 2923 O
fertile 38 45 2924 2931 O
subjects 46 54 2932 2940 O

any 0 3 2941 2944 O
contraindications 4 21 2945 2962 O
to 22 24 2963 2965 O
the 25 28 2966 2969 O
use 29 32 2970 2973 O
of 33 35 2974 2976 O
busulfan 36 44 2977 2985 B-treatment
and 45 48 2986 2989 O
any 49 52 2990 2993 O
other 53 58 2994 2999 O
medicinal 59 68 3000 3009 B-treatment
products 69 77 3010 3018 I-treatment
required 78 86 3019 3027 O
during 87 93 3028 3034 O
the 94 97 3035 3038 O
myeloablative 98 111 3039 3052 B-treatment
conditioning 112 124 3053 3065 I-treatment
, 124 125 3065 3066 O
including 126 135 3067 3076 O
hypersensitivity 136 152 3077 3093 O
to 153 155 3094 3096 O
the 156 159 3097 3100 O
active 160 166 3101 3107 O
substances 167 177 3108 3118 O
or 178 180 3119 3121 O
to 181 183 3122 3124 O
any 184 187 3125 3128 O
of 188 190 3129 3131 O
the 191 194 3132 3135 O
excipients 195 205 3136 3146 O

breastfeeding 0 13 3147 3160 O
in 14 16 3161 3163 O
a 17 18 3164 3165 O
postpartum 19 29 3166 3176 O
female 30 36 3177 3183 B-gender

direct 0 6 3184 3190 B-clinical_variable
bilirubin 7 16 3191 3200 I-clinical_variable
value 17 22 3201 3206 I-clinical_variable
> 23 24 3207 3208 O
3× 24 26 3208 3210 B-lower_bound
the 27 30 3211 3214 I-lower_bound
upper 31 36 3215 3220 I-lower_bound
limit 37 42 3221 3226 I-lower_bound
of 43 45 3227 3229 I-lower_bound
normal 46 52 3230 3236 I-lower_bound
( 53 54 3237 3238 I-lower_bound
ULN 54 57 3238 3241 I-lower_bound
) 57 58 3241 3242 I-lower_bound

in 0 2 3243 3245 O
the 3 6 3246 3249 O
setting 7 14 3250 3257 O
of 15 17 3258 3260 O
appropriate 18 29 3261 3272 O
supportive 30 40 3273 3283 O
care 41 45 3284 3288 O
measures 46 54 3289 3297 O
for 55 58 3298 3301 O
SCD 59 62 3302 3305 B-chronic_disease
( 63 64 3306 3307 O
e.g. 64 68 3307 3311 O
,pain 68 73 3311 3316 O
management 74 84 3317 3327 O
plan 85 89 3328 3332 O
) 89 90 3332 3333 O
have 91 95 3334 3338 O
experienced 96 107 3339 3350 O
at 108 110 3351 3353 O
least 111 116 3354 3359 O
4 117 118 3360 3361 B-lower_bound
severe 119 125 3362 3368 O
VOEs 126 130 3369 3373 B-chronic_disease
in 131 133 3374 3376 O
the 134 137 3377 3380 O
24 138 140 3381 3383 B-upper_bound
months 141 147 3384 3390 I-upper_bound
prior 148 153 3391 3396 I-upper_bound
to 154 156 3397 3399 O
informed 157 165 3400 3408 O
consent 166 173 3409 3416 O

occlusion 0 9 3417 3426 B-chronic_disease
or 10 12 3427 3429 O
stenosis 13 21 3430 3438 B-chronic_disease
in 22 24 3439 3441 O
the 25 28 3442 3445 O
polygon 29 36 3446 3453 O
of 37 39 3454 3456 O
Willis 40 46 3457 3463 O

overt 0 5 3464 3469 O
or 6 8 3470 3472 O
hemorrhagic 9 20 3473 3484 B-chronic_disease
stroke 21 27 3485 3491 I-chronic_disease

patients 0 8 3492 3500 O
on 9 11 3501 3503 O
prophylactic 12 24 3504 3516 O
doses 25 30 3517 3522 O
of 31 33 3523 3525 O
anticoagulants 34 48 3526 3540 B-treatment

presence 0 8 3541 3549 O
of 9 11 3550 3552 O
Moyamoya 12 20 3553 3561 B-chronic_disease
disease 21 28 3562 3569 I-chronic_disease

previously 0 10 3570 3580 O
treated 11 18 3581 3588 O
, 18 19 3588 3589 O
non 20 23 3590 3593 O
- 23 24 3593 3594 O
life 24 28 3594 3598 O
threatening 29 40 3599 3610 O
, 40 41 3610 3611 O
cured 42 47 3612 3617 O
tumors 48 54 3618 3624 B-cancer
such 55 59 3625 3629 O
as 60 62 3630 3632 O
squamous 63 71 3633 3641 B-cancer
cell 72 76 3642 3646 I-cancer
carcinoma 77 86 3647 3656 I-cancer
of 87 89 3657 3659 O
the 90 93 3660 3663 O
skin 94 98 3664 3668 O

priapism 0 8 3669 3677 B-chronic_disease
does 9 13 3678 3682 O
not 14 17 3683 3686 O
require 18 25 3687 3694 O
hospital 26 34 3695 3703 O
admission 35 44 3704 3713 O
but 45 48 3714 3717 O
does 49 53 3718 3722 O
require 54 61 3723 3730 O
a 62 63 3731 3732 O
medical 64 71 3733 3740 O
facility 72 80 3741 3749 O
visit 81 86 3750 3755 O

suspected 0 9 3756 3765 O
of 10 12 3766 3768 O
arising 13 20 3769 3776 O
from 21 25 3777 3781 O
liver 26 31 3782 3787 B-chronic_disease
disease 32 39 3788 3795 I-chronic_disease

